Expulsion rates of the levonorgestrel 52 mg intrauterine system are similar among women with heavy menstrual bleeding and users for contraception.
Sign Up to like & getrecommendations! Published in 2021 at "Contraception"
DOI: 10.1016/j.contraception.2021.09.001
Abstract: OBJECTIVE To compare the expulsion rates of the levonorgestrel (LNG) 52 mg intrauterine system (IUS) among women with heavy menstrual bleeding versus women using solely for contraception. STUDY DESIGN We conducted an audit study of… read more here.
Keywords: heavy menstrual; menstrual bleeding; among women; expulsion rates ... See more keywords
Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas
Sign Up to like & getrecommendations! Published in 2020 at "Obstetrics and Gynecology"
DOI: 10.1097/aog.0000000000003869
Abstract: Up to 12 months of elagolix with add-back therapy provided sustained reduction in menstrual blood loss with an acceptable safety profile in women with uterine leiomyomas. read more here.
Keywords: women heavy; uterine leiomyomas; elagolix treatment; heavy menstrual ... See more keywords
The combined use of endometrial ablation or resection and levonorgestrel‐releasing intrauterine system in women with heavy menstrual bleeding: A systematic review
Sign Up to like & getrecommendations! Published in 2021 at "Acta Obstetricia et Gynecologica Scandinavica"
DOI: 10.1111/aogs.14219
Abstract: Despite endometrial ablation/resection being a very successful treatment for women with heavy menstrual bleeding, re‐intervention with additional surgery is needed in 12%–25% of cases. Introducing a levonorgestrel‐intrauterine system (LNG‐IUS) immediately after ablation could preserve the… read more here.
Keywords: endometrial ablation; ablation; heavy menstrual; menstrual bleeding ... See more keywords